Correlation Between Moleculin Biotech and Avenue Therapeutics
Can any of the company-specific risk be diversified away by investing in both Moleculin Biotech and Avenue Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moleculin Biotech and Avenue Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moleculin Biotech and Avenue Therapeutics, you can compare the effects of market volatilities on Moleculin Biotech and Avenue Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moleculin Biotech with a short position of Avenue Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moleculin Biotech and Avenue Therapeutics.
Diversification Opportunities for Moleculin Biotech and Avenue Therapeutics
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Moleculin and Avenue is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Moleculin Biotech and Avenue Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avenue Therapeutics and Moleculin Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moleculin Biotech are associated (or correlated) with Avenue Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avenue Therapeutics has no effect on the direction of Moleculin Biotech i.e., Moleculin Biotech and Avenue Therapeutics go up and down completely randomly.
Pair Corralation between Moleculin Biotech and Avenue Therapeutics
Given the investment horizon of 90 days Moleculin Biotech is expected to generate 1.31 times more return on investment than Avenue Therapeutics. However, Moleculin Biotech is 1.31 times more volatile than Avenue Therapeutics. It trades about -0.04 of its potential returns per unit of risk. Avenue Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 459.00 in Moleculin Biotech on August 30, 2024 and sell it today you would lose (190.00) from holding Moleculin Biotech or give up 41.39% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Moleculin Biotech vs. Avenue Therapeutics
Performance |
| Timeline |
| Moleculin Biotech |
| Avenue Therapeutics |
Moleculin Biotech and Avenue Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Moleculin Biotech and Avenue Therapeutics
The main advantage of trading using opposite Moleculin Biotech and Avenue Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moleculin Biotech position performs unexpectedly, Avenue Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avenue Therapeutics will offset losses from the drop in Avenue Therapeutics' long position.| Moleculin Biotech vs. Pulmatrix | Moleculin Biotech vs. Cyclacel Pharmaceuticals | Moleculin Biotech vs. Akari Therapeutics PLC | Moleculin Biotech vs. Bio Path Holdings |
| Avenue Therapeutics vs. Hoth Therapeutics | Avenue Therapeutics vs. Revelation Biosciences | Avenue Therapeutics vs. Neurobo Pharmaceuticals | Avenue Therapeutics vs. Virax Biolabs Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |